| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Narendra Wajapeyee
|
|||||||
| GSE178211 |
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models
|
18 | Narendra Wajapeyee | Apr 29, 2024 | ||||
| GSE167071 |
Analysis of open chromatin structures in HCC827 CBX5 knockdown cells by ATAC seq analysis .
|
9 | Narendra Wajapeyee | Feb 18, 2024 | ||||
| GSE150225 |
The role of MSK1 in pancreatic adenocarcinoma (PDAC) progression
|
18 | Narendra Wajapeyee | Nov 02, 2023 | ||||
| GSE165449 |
Study the differential gene expression in SK-MEL-147 cells treated with different epigenetic modulator
|
21 | Narendra Wajapeyee | Nov 01, 2023 | ||||
| GSE146944 |
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein
|
9 | Narendra Wajapeyee | Oct 30, 2023 | ||||
| GSE150222 |
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein
|
9 | Narendra Wajapeyee | Oct 30, 2023 | ||||
| GSE150223 |
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein
|
9 | Narendra Wajapeyee | Oct 30, 2023 | ||||
| GSE190479 |
LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition
|
18 | Narendra Wajapeyee | Mar 16, 2023 | ||||
| GSE114563 |
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer
|
9 | Narendra Wajapeyee | Jan 05, 2023 | ||||
| GSE164974 |
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
|
12 | Narendra Wajapeyee | Aug 02, 2022 | ||||
| GSE164976 |
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
|
12 | Narendra Wajapeyee | Aug 02, 2022 | ||||
| GSE101399 |
Study the differential gene expression of different lung cancer EGFR mutants in NIH3T3 cells
|
15 | Narendra Wajapeyee | Apr 04, 2022 | ||||
| GSE160176 |
Study the differential gene expression of C57/BL6 Mouse tumors treated with EZH2 inhibitor GSK343 II
|
20 | Narendra Wajapeyee | Oct 25, 2021 | ||||
| GSE166553 |
Study the differential gene expression of HEPA1-6 tumors in C57/BL6 Mouse tumors treated with vehicle or EZH2 inhibitor GSK343
|
10 | Narendra Wajapeyee | Jul 10, 2021 | ||||
| GSE83907 |
The role of MELK in melanoma progression
|
12 | Narendra Wajapeyee | Dec 30, 2020 | ||||
| GSE107184 |
The role of KLF7 in pancreatic adenocarcinoma (PDAC) progression
|
9 | Narendra Wajapeyee | Apr 16, 2020 | ||||
| GSE90483 |
Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression
|
4 | Narendra Wajapeyee | Sep 23, 2019 | ||||
| GSE106539 |
Transcriptome-wide gene expression analysis of the cancer cell lines after treatiment with telomerase inhibitor Imetelstat (GRN163L)
|
6 | Narendra Wajapeyee | Jul 19, 2018 | ||||
| GSE76440 |
Metabolic drivers of ovarian cancer tumor growth
|
6 | Narendra Wajapeyee | Aug 13, 2017 | ||||
| GSE62827 |
Transcriptional targets of oncogenic RAS proteins that mediate their ability to induce cellular transformation
|
12 | Narendra Wajapeyee | Sep 08, 2016 |
